TY  - JOUR
AU  - Lewinska, Monika
AU  - Santos-Laso, Alvaro
AU  - Arretxe, Enara
AU  - Alonso, Cristina
AU  - Zhuravleva, Ekaterina
AU  - Jimenez-Aguero, Raul
AU  - Eizaguirre, Emma
AU  - Jesus Pareja, Maria
AU  - Romero-Gomez, Manuel
AU  - Arrese, Marco
AU  - Suppli, Malte P.
AU  - Knop, Filip K.
AU  - Oversoe, Stine Karlsen
AU  - Villadsen, Gerda Elisabeth
AU  - Decaens, Thomas
AU  - Carrilho, Flair Jose
AU  - de Oliveira, Claudia P. M. S.
AU  - Sangro, Bruno
AU  - Macias, Rocio I. R.
AU  - Banales, Jesus M.
AU  - Andersen, Jesper B.
PY  - 2021
DO  - 10.1016/j.ebiom.2021.103661
SN  - 2352-3964
UR  - https://hdl.handle.net/10668/26530
T2  - Ebiomedicine
AB  - Background: Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic...
LA  - en
PB  - Elsevier
KW  - NAFLD
KW  - HCC
KW  - metabolomics
KW  - lipidomics
KW  - biomarker discovery
KW  - Disease
KW  - Obesity
TI  - The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
TY  - research article
VL  - 73
ER  -